ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q Nov 15, 2023 QUARTERLY REPORT
NT 10-Q Nov 14, 2023 NOTIFICATION OF LATE FILING
8-K Sep 13, 2023 CURRENT REPORT
8-K/A Sep 6, 2023 AMENDMENT NO. 1 TO FORM 8-K
8-K Aug 31, 2023 CURRENT REPORT
424B4 Aug 17, 2023 PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023.
424B4 Aug 17, 2023 PROSPECTUS SUPPLEMENT NO. 1 DATED AUGUST 16, 2023.
424B3 Aug 17, 2023 PROSPECTUS SUPPLEMENT NO. 2 DATED AUGUST 16, 2023.
8-K Aug 17, 2023 CURRENT REPORT
10-Q Aug 14, 2023 QUARTERLY REPORT
8-K/A Aug 9, 2023 AMENDMENT NO. 1 TO FORM 8-K
SC 13G Aug 7, 2023
8-K Aug 7, 2023 CURRENT REPORT
8-K Aug 2, 2023 CURRENT REPORT
8-K Jul 31, 2023 CURRENT REPORT
424B5 Jul 31, 2023 PROSPECTUS SUPPLEMENT
8-K Jul 27, 2023 CURRENT REPORT
8-K Jul 24, 2023 CURRENT REPORT
8-K/A Jul 14, 2023 FORM 8-K/A
8-K Jul 7, 2023 CURRENT REPORT
8-K Jun 23, 2023 CURRENT REPORT
DEF 14A Jun 21, 2023 DEFINITIVE PROXY STATEMENT
8-K Jun 15, 2023 CURRENT REPORT
424B4 Jun 12, 2023 PROSPECTUS
8-K Jun 9, 2023 CURRENT REPORT
← Newer Page 7 of 32 · 793 filings Older →